Simon Akerman Selected Research

Simon Akerman Research Topics

Disease

41	Migraine Disorders (Migraine) 09/2023 - 10/2002
11	Headache (Headaches) 09/2023 - 09/2005
7	Epilepsy (Aura) 01/2019 - 08/2005
6	Cluster Headache (Cluster Headaches) 09/2023 - 08/2004
6	Pain (Aches) 10/2021 - 01/2013
4	Hypersensitivity (Allergy) 10/2021 - 10/2015
4	Neoplasms (Cancer) 12/2013 - 04/2008
3	Hyperalgesia 09/2023 - 01/2019
2	Primary Headache Disorders 01/2021 - 01/2021
2	Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania) 01/2021 - 12/2010
2	Migraine with Aura (Familial Hemiplegic Migraine) 04/2014 - 10/2012
2	Necrosis 12/2013 - 03/2010
2	Fibrosarcoma 12/2013 - 04/2008
1	Chronic Pain 10/2021
1	Inflammation (Inflammations) 12/2020
1	Facial Pain (Myofacial Pain) 09/2015
1	Myalgia 09/2015
1	Atrial Fibrillation 03/2015
1	Cardiac Arrhythmias (Arrythmia) 03/2015
1	Secondary Headache Disorders 03/2014
1	Trigeminal Autonomic Cephalalgias 12/2012
1	Headache Disorders (Headache Syndromes) 12/2010
1	Sarcoma (Soft Tissue Sarcoma) 03/2010

Drug/Important Bio-Agent (IBA)

7	Calcitonin Gene-Related PeptideIBA 10/2021 - 11/2002
7	Tryptamines (Triptans)IBA 01/2021 - 12/2012
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2021 - 10/2002
5	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021 - 08/2004
4	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2023 - 10/2015
4	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 09/2023 - 10/2015
3	NeuropeptidesIBA 09/2023 - 10/2015
3	Nitroglycerin (Dynamite)FDA LinkGeneric 08/2022 - 01/2018
3	Indomethacin (Indometacin)FDA LinkGeneric 01/2021 - 12/2010
3	Peptides (Polypeptides)IBA 03/2018 - 10/2015
3	Protein Isoforms (Isoforms)IBA 01/2018 - 04/2008
3	Topiramate (Topamax)FDA LinkGeneric 03/2014 - 08/2005
2	Sumatriptan (Imigran)FDA LinkGeneric 09/2023 - 01/2020
2	Analgesics (Analgesic Drugs)IBA 03/2022 - 01/2021
2	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2020 - 10/2015
2	Therapeutic UsesIBA 01/2019 - 09/2013
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 03/2018 - 10/2015
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2018 - 11/2002
2	5-HT1F Serotonin ReceptorIBA 04/2017 - 01/2017
2	Anticonvulsants (Antiepileptic Drugs)IBA 03/2014 - 09/2005
2	TubulinIBA 12/2013 - 04/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013 - 04/2008
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 12/2012 - 08/2004
2	Oxygen (Dioxygen)IBA 12/2012 - 09/2009
2	TRPV1 receptorIBA 11/2012 - 01/2011
2	Dopamine (Intropin)FDA LinkGeneric 06/2010 - 11/2009
1	Peroxynitrous Acid (Peroxynitrite)IBA 10/2021
1	vofopitantIBA 01/2021
1	Cyclooxygenase InhibitorsIBA 01/2021
1	Freund's AdjuvantIBA 12/2020
1	Small Interfering RNA (siRNA)IBA 08/2019
1	Lamotrigine (Lamictal)FDA LinkGeneric 01/2019
1	gastrodinIBA 01/2018
1	tetramethylpyrazineIBA 01/2018
1	Glucagon (Glukagon)FDA Link 05/2017
1	Glucose (Dextrose)FDA LinkGeneric 05/2017
1	Insulin (Novolin)FDA Link 05/2017
1	LeptinIBA 05/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Neuropeptide YIBA 01/2016
1	Metabotropic Glutamate 5 ReceptorIBA 01/2016
1	Vasodilator Agents (Vasodilators)IBA 10/2015
1	CytokinesIBA 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	MK-8825IBA 09/2015
1	dofetilide (Tikosyn)FDA Link 03/2015
1	Orexin Receptor AntagonistsIBA 02/2015
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 04/2014
1	voltage-dependent calcium channel (P-Q type)IBA 04/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2013
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2013
1	Semaxinib (SU5416)IBA 12/2013
1	OxindolesIBA 12/2013
1	fosbretabulin (combretastatin A4)IBA 12/2013
1	EndocannabinoidsIBA 09/2013
1	olcegepantIBA 12/2012
1	Naproxen (Naprosyn)FDA LinkGeneric 12/2012
1	Amiloride (Midamor)FDA LinkGeneric 10/2012
1	Acid Sensing Ion ChannelsIBA 10/2012
1	combretastatinIBA 10/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2010
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2010
1	Dopamine AntagonistsIBA 06/2010
1	Dopamine beta-HydroxylaseIBA 06/2010
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2010
1	Biogenic Amines (Biogenic Amine)IBA 06/2010
1	Dendrimers (Dendrons)IBA 03/2010
1	Protamines (Protamine Sulfate)FDA Link 03/2010

Therapy/Procedure

12	Therapeutics 03/2022 - 04/2008
3	Vagus Nerve Stimulation 03/2022 - 06/2017
2	Transcranial Magnetic Stimulation 03/2022 - 01/2016
2	Lasers (Laser) 09/2008 - 08/2005
1	Intravenous Infusions 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Immunomodulation 03/2018